Please login to the form below

Not currently logged in

Darwin's Medicine blog

Professor Brian D Smith is an authority on the pharmaceutical industry and works at SDA Bocconi University and Hertfordshire Business School.

Darwin abstraction Awesome abstraction

23 Mar 2020

Business development deals and commercial operating models show the power of Generalised Darwinism

  • darwins medicine Digital divergence

    21 Feb 2020

    Combining digital and pharma is proving less easy than previously thought

  • darwins medicine Blood will out

    22 Jan 2020

    Think carefully about the DNA you’re acquiring

  • darwins medicine Blind man's buff

    06 Dec 2019

    Evolution can explain, and reduce, industry failings as well as its successes

  • darwins medicine The end of pharma

    13 Nov 2019

    Some parts of our industry may go the way of the kitchen display cabinet and the word processor

  • darwins medicine Breaking the cookie cutter

    16 Oct 2019

    Differentiated strategies need differentiated thinking

  • darwins medicine Why Marry?

    25 Sep 2019

    Just like people, firms marry for many different reasons

  • darwins medicine Edging Evolution

    06 Aug 2019

    You don’t have to wait for your business to evolve

  • darwins medicine Deep Value

    07 May 2019

    Value-based healthcare is difficult because it’s deep

  • darwins medicine It's Complicated

    29 Apr 2019

    Commercial executives should be more like their scientist colleagues

1 2 3 4 5


COVID-19 Updates and Daily News

Featured jobs


Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...